| NO. | Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|---|
| S-140 | 08:00-08:18 | 08:00-08:18 |
Fibrotic stenosis in Crohn's disease: pathogenesis and treatment prospects |
Ren Mao | The First Affiliated Hospital of Sun Yat-sen University |
| 08:18-08:23 | 08:18-08:23 |
Discussion 3min |
|||
| S-141 | 08:23-08:41 | 08:23-08:41 |
How to detect and respond to anorectal and fistula tumors in perianal Crohn's disease |
Jie Liang | The First Affiliated Hospital of Air Force Medical University of the Chinese People's Liberation Army |
| 08:41-08:46 | 08:41-08:46 |
Discussion 3min |
|||
| S-142 | 08:46-09:04 | 08:46-09:04 |
Current and future microbiota based treatments for inflammatory bowel disease |
Ling Liu | West China Hospital of Sichuan University |
| 09:04-09:09 | 09:04-09:09 |
Discussion 3min |
|||
| NO. | Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|---|
| S-143 | 09:09-09:27 | 09:09-09:27 |
Downgrading and reduction of biologic therapy for inflammatory bowel disease: application and controversy |
Jun Shen | Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine |
| 09:27-09:32 | 09:27-09:32 |
Discussion 3min |
|||
| S-144 | 09:32-09:50 | 09:32-09:50 |
From susceptibility genes and epigenetic modifications to precision medicine: the combination of basic and clinical aspects of inflammatory bowel disease |
Zhanju Liu | Shanghai Tenth People's Hospital, Tongji University |
| 09:50-09:55 | 09:50-09:55 |
Discussion 3min |
|||
| NO. | Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|---|
| OR-106 | 10:10-10:20 | 10:10-10:20 |
Macrophage-Derived Asparagine Promotes Fibroblast Proliferation and Drives Intestinal Fibrosis |
Haiming Zhuang | Ruijin Hospital, Shanghai Jiaotong University School of Medicine |
| 10:20-10:25 | 10:20-10:25 |
Discussion 3min |
|||
| OR-107 | 10:25-10:35 | 10:25-10:35 |
Efficacy and Safety of Guselkumab in Patients with Moderate to Severe Active Crohn's Disease: Results from the GALAXI 2 & 3 Phase III Trials |
Baili Chen | The First Affiliated Hospital of Sun Yat-sen University |
| 10:35-10:40 | 10:35-10:40 |
Discussion 3min |
|||
| OR-108 | 10:40-10:50 | 10:40-10:50 |
Clinical Application of Bile Acid Metabolism Typing in Crohn's Disease |
Xiaozhi Li | The First Affiliated Hospital Of Sun Yat-sen University |
| 10:50-10:55 | 10:50-10:55 |
Discussion 3min |
|||
| OR-109 | 10:55-11:05 | 10:55-11:05 |
DSS-induced colitis combined with high-protein diet delays intestinal epithelial repair |
Li Zeng | West China Hospital, Sichuan University |
| 11:05-11:10 | 11:05-11:10 |
Discussion 3min |
|||
| NO. | Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|---|
| C-36 | 11:10-11:55 | 11:10-11:55 |
Diagnosis and Treatment of a Patient with Refractory Diarrhea Complicated by Gastric Cancer: Unraveling the True Culprit |
Yao He | The First Affiliated Hospital of Sun Yat-sen University |
| NO. | Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|---|
| T-18 | 12:00-12:30 | 12:00-12:30 |
From practice to inspiration: a real-world experience with upadacitinib in IBD treatment |
Qian Cao | Sir Run Run Shaw Hospital, Zhejiang University School of Medicine |
| NO. | Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|---|
| T-19 | 12:30-12:50 | 12:30-12:50 |
IL-23 and UC: From Clinical Status to Ideal Treatment, Applications and Innovations of IL-23i |
Xiaolan Zhang | The Second Affiliated Hospital of Hebei Medical University Health Science Center |
| T-20 | 12:50-13:10 | 12:50-13:10 |
IL-23 and CD: From Molecular Mechanisms to Clinical Research, Prospects and Differences of IL-23i |
Baili Chen | The First Affiliated Hospital of Sun Yat-sen University |
| 13:10-13:30 | 13:10-13:30 |
Panel Discussion
Zhanju Liu
Shanghai Tenth People's Hospital, Tongji University
Yue Li Peking Union Medical College Hospital, Chinese Academy of Medical Sciences Baili Chen The First Affiliated Hospital of Sun Yat-sen University |
|||
| NO. | Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|---|
| PL-42 | 13:30-13:50 | 13:30-13:50 |
Establishment of a non-invasive diagnosis of metabolic fatty liver based on an intestinal targeted strain of Escherichia coli NF73-1 |
Yulan Liu | Peking University People's Hospital |
| 13:50-13:57 | 13:50-13:57 |
Discussion 5min |
|||
| PL-43 | 13:57-14:17 | 13:57-14:17 |
Study on early diagnosis and intervention strategies of refractory PBC |
Ying Han | The First Affiliated Hospital of Air Force Medical University of the Chinese People's Liberation Army |
| 14:17-14:24 | 14:17-14:24 |
Discussion 5min |
|||
| PL-44 | 14:24-14:44 | 14:24-14:44 |
The role of novel organelles in hepatic lipidosis |
Chaohui Yu | The First Affiliated Hospital, Zhejiang University School of Medicine |
| 14:44-14:51 | 14:44-14:51 |
Discussion 5min |
|||
| PL-45 | 14:51-15:11 | 14:51-15:11 |
Study on the mechanism of SLC35C1 overexpression in alleviating liver injury in cholestasis |
Qiong Pan | THE SOUTHWEST HOSPITAL OF AMU |
| 15:11-15:18 | 15:11-15:18 |
Discussion 5min |
|||
| PL-41 | 15:18-15:38 | 15:18-15:38 |
The paradigms and technological systems for precision hepatobiliary surgery |
Jiahong Dong | Beijing Tsinghua Chang Gung hospital |
| 15:38-15:45 | 15:38-15:45 |
Discussion 5min |
|||
| NO. | Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|---|
| S-145 | 16:00-16:15 | 16:00-16:15 |
Biological artificial liver support : the past, present, and future |
Fengmei Wang | Tianjin First Central Hospital |
| 16:15-16:20 | 16:15-16:20 |
Discussion 3min |
|||
| S-146 | 16:20-16:35 | 16:20-16:35 |
Human albumin in complications associated with cirrhosis of the liver |
Xingshun Qi | General Hospital of Northern Theater Command |
| 16:35-16:40 | 16:35-16:40 |
Discussion 3min |
|||
| S-147 | 16:40-16:55 | 16:40-16:55 |
Pathophysiological significance, mechanism and intervention studies of cyclooxygenase-2 mediated bile duct response associated with hepatocyte injury |
Tian Lan | Lab. of Gastroenterology & Hepatology, West China Hospital, Sichuan University |
| 16:55-17:00 | 16:55-17:00 |
Discussion 3min |
|||
| S-148 | 17:00-17:15 | 17:00-17:15 |
Cell lineage tracing combined with multiple immunofluorescence staining in the study of liver disease |
Xing Deng | Changzheng Hospital, Second Military Medical University |
| 17:15-17:20 | 17:15-17:20 |
Discussion 3min |
|||
| S-149 | 17:20-17:35 | 17:20-17:35 |
The relationship between liver immune microenvironment and tumours |
Limin Xia | Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology |
| 17:35-17:40 | 17:35-17:40 |
Discussion 3min |
|||